|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-09S1
|
$69,244
|
$69,244
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-09
|
$443,347
|
$443,347
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-12
|
$203,525
|
$10,176
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-05
|
$279,728
|
$95,108
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$31,826
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
1F31CA132560-01A1
|
$27,772
|
$27,772
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
1R43CA134172-01
|
$112,978
|
$112,978
|
Houghton, Michael
|
EPIPHANY BIOSCIENCES, INC.
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S4
|
$9,979,932
|
$99,799
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S5
|
$60,810
|
$608
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$2,640
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The East Coast AIDS and Cancer Specimen Resource
|
2U01CA066535-14
|
$1,015,469
|
$253,867
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
$76,631
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-12
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$148,414
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bim regulation by HHV-8 vIRF-1
|
1R21CA136356-01
|
$184,500
|
$184,500
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-09
|
$348,813
|
$174,407
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
HHV-8 vGPCR Signaling in Virus Biology
|
5R21CA119887-02
|
$196,800
|
$196,800
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
An Animal Model for Kaposi's Sarcoma
|
5K08CA103858-05
|
$133,083
|
$133,083
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Role of Chemokine Receptor ORF74 in Angioproliferation
|
5R01CA109259-05
|
$329,470
|
$329,470
|
LIRA, SERGIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
Z01 BC 009101
|
$135,938
|
$40,781
|
Appella, Ettore
|
CCR (NCI)
|
|
HIV Tat Transcriptional Activation
|
Z01 BC 005753
|
$291,643
|
$58,329
|
Brady, John
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
Z01 BC 007363
|
$261,903
|
$222,618
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
Z01 BC 010791
|
$737,332
|
$73,733
|
Carrington, Mary
|
CCR (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
Z01 CP010150-10362
|
$318,791
|
$31,879
|
Engels, Eric
|
DCEG (NCI)
|
|
Medical Oncology Fellowship Program
|
Z01 BC 010843
|
$3,900,000
|
$78,000
|
Fojo, Antonio
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
Z01 BC 005598
|
$758,163
|
$75,816
|
Gottesman, Michael
|
CCR (NCI)
|
|
Molecular Therapeutics for HIV/AIDS
|
Z01 BC 010530
|
$378,837
|
$75,767
|
Hamer, Dean
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,300,000
|
$65,000
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
Z01 BC 006174
|
$190,292
|
$28,544
|
Marquez, Victor
|
CCR (NCI)
|
|
HIV AIDS cancer match, U.S.
|
Z01 CP010176-10071
|
$340,213
|
$102,064
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
HIV/AIDS Lymphomas
|
Z01 CP010176-10074
|
$586,184
|
$175,855
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
Z01 CP010176-10076
|
$126,127
|
$63,063
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
Classical KS case-control studies
|
Z01 CP010176-10077
|
$339,387
|
$339,387
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
Z01 CP010176-10082
|
$78,036
|
$78,036
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
AIDS cancer match, non-U.S.
|
Z01 CP010176-10084
|
$188,362
|
$131,853
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
Z01 BC 010936
|
$225,165
|
$56,291
|
McKinnon, Katherine
|
CCR (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor Development
|
Z01 BC 010524
|
$150,248
|
$150,248
|
Nicklaus, Marc
|
CCR (NCI)
|
|
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts
|
Z01 BC 010317
|
$973,129
|
$486,565
|
O'Brien, Stephen
|
CCR (NCI)
|
|
Human Immunodeficiency Virus Epidemiology Research Study (HERS)
|
Z01 CP005782-10426
|
$116,499
|
$46,600
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
DNA Vaccines
|
Z01 BC 010749
|
$773,387
|
$77,339
|
Pavlakis, George
|
CCR (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
Z01 BC 011079
|
$1,067,000
|
$21,340
|
Raffeld, Mark
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
Z01 BC 011058
|
$949,953
|
$949,953
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
Z01 BC 011062
|
$949,953
|
$949,953
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Translation to the Clinic
|
Z01 BC 011063
|
$211,100
|
$211,101
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
|
Z01 BC 010252
|
$571,845
|
$57,185
|
Ruscetti, Francis
|
CCR (NCI)
|
|
High-Throughput Genotyping for Genetic Epidemiology
|
Z01 BC 010270
|
$215,486
|
$107,743
|
Smith, Michael
|
CCR (NCI)
|
|
Identification of Genes Involved in HIV-1/AIDS, HBV and HCV
|
Z01 BC 010271
|
$215,486
|
$107,743
|
Smith, Michael
|
CCR (NCI)
|
|
Identification of Needle Sharing: A Risk Factor for Viral Infection
|
Z01 BC 010306
|
$92,351
|
$23,088
|
Smith, Michael
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
Z01 SC 007202
|
$523,530
|
$26,177
|
Steinberg, Seth
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
Z01 SC 010356
|
$365,279
|
$365,280
|
Tosato, Giovanna
|
CCR (NCI)
|
Total relevant funding to Kaposi Sarcoma for this search: $26,986,912
|